HAVCR2 and lymphangioleiomyomatosis: Considering the reported information on the relevance of TIM3/GAL9 pathway in the defense against mycobacterial infections, it is still not clear whether LAM may modify TIM3/GAL9 pathway and impair host defense mechanisms.